News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-20 5:17:57 am Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility GlobeNewsWire
2024-03-13 6:0:0 am Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024 GlobeNewswire
2024-03-06 6:0:0 am Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution GlobeNewswire
2024-02-28 6:0:0 am Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF GlobeNewswire
2024-02-06 5:30:0 am Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer GlobeNewswire
2024-01-26 5:0:0 am Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women GlobeNewswire
2024-01-23 5:30:0 am Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information